SignPath Pharma, Inc.
company.status.inactiveCIK 1455694fmd_1P77PWYY2JPBMBH8XYXHJQ2763Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2007 to Jun 30, 2016, 28 periods
Latest annual · FY2015
Millions- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q2 FY2016
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2010 to FY2015
- n/m
SignPath Pharma, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.6 million | -$2.7 million | 10-K 2016-04-08 · proof | |
| Net income | -$1.6 million | -$2.7 million | 10-K 2016-04-08 · proof | |
| Cash from operating activities | -$1.5 million | -$2.2 million | 10-K 2016-04-08 · proof | |
| Total assets | $697,933 | $716,193 | -2.5% | 10-K 2016-04-08 · proof |
| Total liabilities | $309,795 | $447,999 | -30.8% | 10-K 2016-04-08 · proof |
| Cash and cash equivalents | $692,480 | $716,193 | -3.3% | 10-K 2016-04-08 · proof |
- What was SignPath Pharma, Inc.'s operating income in fiscal 2015?
- SignPath Pharma, Inc. reported operating income of -$1.6 million for fiscal 2015 (the year ended Dec 31, 2015), against -$2.7 million the year before. Source: the 10-K filed with the SEC on Apr 8, 2016. SEC
- What was SignPath Pharma, Inc.'s net income in fiscal 2015?
- SignPath Pharma, Inc. reported net income of -$1.6 million for fiscal 2015 (the year ended Dec 31, 2015), against -$2.7 million the year before. Source: the 10-K filed with the SEC on Apr 8, 2016. SEC
- What was SignPath Pharma, Inc.'s cash from operating activities in fiscal 2015?
- SignPath Pharma, Inc. reported cash from operating activities of -$1.5 million for fiscal 2015 (the year ended Dec 31, 2015), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Apr 8, 2016. SEC
- What are SignPath Pharma, Inc.'s total assets?
- As of Dec 31, 2015, SignPath Pharma, Inc. reported total assets of $697,933, against $716,193 a year earlier (-2.5%). Source: the 10-K filed with the SEC on Apr 8, 2016. SEC
- What are SignPath Pharma, Inc.'s total liabilities?
- As of Dec 31, 2015, SignPath Pharma, Inc. reported total liabilities of $309,795, against $447,999 a year earlier (-30.8%). Source: the 10-K filed with the SEC on Apr 8, 2016. SEC
- What are SignPath Pharma, Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, SignPath Pharma, Inc. reported cash and cash equivalents of $692,480, against $716,193 a year earlier (-3.3%). Source: the 10-K filed with the SEC on Apr 8, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1455694&period_type=annual&limit=5"Information only, not investment advice.